Journals / Retina-Vitreus / 2007 / Cilt: 15 - Sayı: 2

Use of fundus autofluorescence in hereditary retinal diseases

Fundus otofloresansının herediter retina hastalıklarında kullanımı

Pages
77–80
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It may reveal RPE lipofuscin changes not ophthalmoscopically visible, and it may provide typical images not seen by fluorescein angiography or ophthalmoscopy

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Fluorescence is the property of some molecules to emit light energy of a longer wavelenght when stimulated by a light of a certain wavelength.
📊
Key Findings & Data:Autofluorescence, on the other hand, is emission of fluorescent light from ocular structures in the absence of fluorescein sodium.
💡
Conclusion & Impact:It may reveal RPE lipofuscin changes not ophthalmoscopically visible, and it may provide typical images not seen by fluorescein angiography or ophthalmoscopy
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Fluorescence is the property of some molecules to emit light energy of a longer wavelenght when stimulated by a light of a certain wavelength. Autofluorescence, on the other hand, is emission of fluorescent light from ocular structures in the absence of fluorescein sodium. Fundus autofluorescence (FAF) has been recently introduced as a technique of fundus imaging and is considered to originate from lipofuscin in retinal pigment epithelium (RPE). Hence, this technique can noninvasively evaluate the RPE. FAF can be recorded by specially modified fundus cameras or scanning laser ophthalmoscopes, and it has been used successfully in different retinal disorders. This technique reveals typical findings in patients with hereditary retinal diseases. FAF is an imaging technique that can effectively be used in hereditary retinal disorders. It may reveal RPE lipofuscin changes not ophthalmoscopically visible, and it may provide typical images not seen by fluorescein angiography or ophthalmoscopy

Özet

Floresans; bazı moleküllerin belli bir dalga boyundaki ışıkla uyarılması sonucu daha uzun bir dalga boyunda ışık yaymasıdır. Otofloresans ise sodyum floresein verilmeksizin gözdeki yapılardan floresan ışık yayılımı olarak tanımlanabilir. Fundus otofloresansı (FAF), gözdibi görüntülenmesinde yeni bir teknik olarak yakın zamanda kullanıma girmiştir ve retina pigment epitelindeki (RPE) lipofusinden kaynaklanmaktadır. Bu nedenle FAF, RPE’ni noninvaziv olarak değerlendirilebilen bir tekniktir. FAF görüntülemesi, özel olarak modifiye edilmiş fundus kameraları veya tarayıcı lazer oftalmoskoplarla kaydedilebilmektedir ve farklı fundus hastalıklarında başarıyla kullanılmıştır. Bu metodla, herediter retina hastalıklarında tipik bulgular izlenmektedir. FAF, herediter retina hastalıklarında etkin şekilde kullanılabilecek bir görüntüleme yöntemidir. Oftalmoskopik olarak henüz görülemeyen RPE-lipofusin değişiklikleri bu metodla görülebilmekte, oftalmoskopik bakı ve floresein anjiyografide izlenmeyen tipik görüntüler elde etmek mümkün olabilmektedir.

🔖

Cite This Article

TATLIPINAR, S., AYATA, A., ÜNAL, M., AYDIN, A., ERŞANLI, D., BİLGE, A. H. (2007). Use of fundus autofluorescence in hereditary retinal diseases. Retina-Vitreus, Cilt: 15 - Sayı: 2, 77–80. https://ajindex.com/articles/305250

References (13)

  1. Delori FC, Dorey CK, Staurenghi G, et al.: In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718-729. von Rückman A, Fitzke FW, Bird AC.: Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol. 1995;79:407-412.
  2. Kennedy CJ, Rakocy PE, Constable IJ.: Lipofuscin of the retinal pigment epithelium: a review. Eye. 1995;9:763-771.
  3. Holz FG, Schütt F, Kopitz J, et al.: Inhibition of lysosomal degredative functions in RPE cells by a retinoid component of lipofuscin. Invest Ophthalmol Vis Sci. 1999;40:737-743. Spaide RF. Fundus autofluorescence and age-related macular degeneration. Ophthalmology. 2003;110:392-399.
  4. Bellmann C, Rubin GS, Kabanarou SA, et al.: Fundus autofluorescence imaging compared with different confocal scanning ophthalmoscopes. Br J Ophthalmol. 2003;87:1381-1386.
  5. Lois N, Halfyard AS, Bird AC, et al.: Fundus autofluorescence in Stargardt macular dystrophy-fundus flavimaculatus. Am J Ophthalmol. 2004;138:55-63.
  6. Framme C, Walter A, Gabler B, et al.: Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy. Acta Ophthalmol Scand. 2005;83:161-167.
  7. Spaide RF, Klancnik JM. Fundus autofluorescence and central serous chorioretinopathy. Ophthalmology. 2005;112:825-833.
  8. Wabbels B, Demmler A, Paunescu K, et al.: Fundus autofluorescence in children and teenagers with hereditary retinal diseases. Graefe’s Arch Clin Exp Ophthalmol. 2006;244:36-45.
  9. Robson AG, Saihan Z, Jenkins SA, et al.: Functional characterisation and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol. 2006;90:472-479.
  10. Sawa M, Ober MD, Freund KB, et al.: Fundus autofluorescence in patients with pseudoxanthoma elasticum. Ophthalmology. 2006;113:814-820.
  11. McBain VA, Towsend J, Lois N.: Fundus autofluorescence in exudative age-related macular degeneration. Br J Ophthalmol. 2007;91:491-496. Souied E. Hereditary macular dystrophies. In Coscas G: Atlas of indocyanine green angiography. Elsevier. Paris. 2005:305-335.
  12. Lois N, Holder GE, Bunce C, et al.: Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol. 2001;119:359-369.
  13. Robson AG, El-Amir A, Bailey C, et al.: Pattern ERG correlates of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2003;44:3544-3550.